1849 Bio creates microbes for affordable metal extraction from low-grade copper and gold ores.
1849 Bio has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2024.
1849 Bio's investors include Y Combinator, Monte Carlo Capital, SBXi, Unpopular Ventures.
1849 Bio is headquartered in San Francisco, United States.
1849 Bio creates microbes for affordable metal extraction from low-grade copper and gold ores.
1849 Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"1849 Bio — Funding & Investors." VCBacked, September 25, 2024, https://www.vcbacked.co/company/1849-bio. Accessed July 19, 2026.
VCBacked. (2024). 1849 Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/1849-bio
{{cite web |title=1849 Bio — Funding & Investors |url=https://www.vcbacked.co/company/1849-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated